Speaker illustration

Doctor Dean Nachman

Hadassah - Hebrew University Medical Center Jerusalem, Jerusalem (Israel)

Member of:

European Society of Cardiology
Heart Failure Association

Dr. Dean Nachman received his MD degree from the Faculty of Medicine at the Hebrew University of Jerusalem, Israel, in 2010, graduating Suma Cum-Laude. He earned his specialty in Internal Medicine and Cardiology at Hadassah Medical Center. His scientific work focuses on the bio-convergence field, implementing engineering concepts in basic and translational research, from animal model studies to clinical trials, seeking remedies for unmet needs arising from his clinical experience. His main areas of clinical and scientific interest are heart failure and advanced hemodynamic monitoring, and he has established several research collaborations with renowned scientists. His research has been published in peer-reviewed papers and presented at national and international conferences, receiving several prestigious research grants. Since 2022 he leads the CV Technology Innovation Center comprised of a team of mechanical engineer, data scientists, MSc and MD students a lab manager and CV fellows.

A personalized, 3D printed, polymeric elastic support device for the prevention of post-MI cardiac remodeling

Event: ESC Congress 2024

Topic: Nonpharmacological Treatment

Session: Takotsubo cardiomyopathy and acute coronary syndromes

Thumbnail

Photobiomodulation mitigates diastolic dysfunction, reduces perivascular fibrosis and inflammation, and enhances mitochondrial metabolism and angiogenesis in a mouse model of HFpEF

Event: ESC Congress 2024

Topic: Mitochondria

Session: Inflammation in heart failure

Thumbnail

Patients with hypertension or chronic kidney disease demonstrated reduced diurnal variation in advanced hemodynamic parameters

Event: Heart Failure 2024

Topic: Remote Patient Monitoring and Telehealth

Session: ePosters in e-Cardiology/digital health 1

Thumbnail

Iatrogenic atrial-septal defect as a primary unloading strategy during acute myocardial infarction: insights from patients data based computational hemodynamic and a swine models

Event: Heart Failure 2024

Topic: Nonpharmacological Treatment

Session: New tools to detect and treat acute heart failure

Thumbnail

Photobiomodulation attenuates myocardial fibrosis and diastolic dysfunction in a mouse model of heart-failure with preserved ejection fraction

Event: ESC Congress 2023

Topic: Heart Failure

Session: Myocardial remodelling (3)

Thumbnail

Photobiomodulation attenuates diastolic functional deterioration in a mouse model of heart-failure with preserved ejection fraction

Event: Heart Failure 2023

Topic: Heart Failure

Session: Basic science - cardiac disease 1

Thumbnail

Continuous monitoring of advanced hemodynamic parameters during hemodialysis demonstrated early variations in patients experiencing intradialytic hypotension

Event: Heart Failure 2023

Topic: Nonpharmacological Treatment

Session: Acute heart failure - treatment 1

Thumbnail

Noninvasive photoplethysmography-based monitor allows SVR and CI measurements comparable to invasive right heart catheterization regardless of skin tone and body habitus

Event: Heart Failure 2023

Topic: Invasive Haemodynamic Monitoring

Session: Acute heart failure - diagnostic methods

Thumbnail

Insights into diurnal variations of advanced hemodynamic parameters in ambulatory individuals enabled by a photoplethysmography-based wearable monitor

Event: ESC Congress 2022

Topic: Remote Patient Monitoring

Session: e-Cardiology/Digital health - Remote monitoring 1

Thumbnail

24-hour ambulatory blood pressure measurement using a novel non-invasive, cuff-less, wireless device

Event: ESC Congress 2021 - The Digital Experience

Topic: Diagnostic Methods

Session: Hypertension e-posters

Thumbnail